Our recent work demonstrated that IFNAR1 was downregulated on all types of cells in the tumor microenvironment of colorectal cancers leading to inactivation of the IFN1 pathway and generation of immune-privileged niches32,33. This evidence concerns the gene IFNAR1 and neoplasm.